Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Blondel

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Plos One|August 27, 2013
The toll-like receptor agonist imiquimod is active against prionsNassima Oumata, Phu Hai Nguyen, Vincent Beringue, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2011
A yeast-based assay identifies drugs active against human mitochondrial disordersElodie Couplan, Raeka S Aiyar, Roza Kucharczyk, et al.
Nature Communications|July 8, 2017
Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNAMaría José Lista, Rodrigo Prado Martins, Olivier Billant, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 3, 2021
Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 AggregationAline Bamia, Maha Sinane, Rima Naït-Saïdi, et al.
Trends in Genetics : TIG|June 4, 2026
Emerging role of G-quadruplexes in alternative splicing regulationAline Peynet, Ronan Le Sénéchal, Marc Keruzoré, et al.
Vaccine|September 26, 2024
Saccharomyces cerevisiae as a platform for vaccination against bovine mastitisCélya Danzelle, Patricia Cunha, Pablo Gomes Noleto, et al.
European Journal of Medicinal Chemistry|June 8, 2019
Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNAOksana Reznichenko, Alicia Quillévéré, Rodrigo Prado Martins, et al.
Oncogene|April 13, 2004
Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubinsMarie Knockaert, Marc Blondel, Stéphane Bach, et al.
Disease Models & Mechanisms|June 3, 2015
Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapiesJean-Paul Lasserre, Alain Dautant, Raeka S Aiyar, et al.
Plos One|May 15, 2008
Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugsDéborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Plos One|August 27, 2013
The toll-like receptor agonist imiquimod is active against prionsNassima Oumata, Phu Hai Nguyen, Vincent Beringue, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2011
A yeast-based assay identifies drugs active against human mitochondrial disordersElodie Couplan, Raeka S Aiyar, Roza Kucharczyk, et al.
Nature Communications|July 8, 2017
Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNAMaría José Lista, Rodrigo Prado Martins, Olivier Billant, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 3, 2021
Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 AggregationAline Bamia, Maha Sinane, Rima Naït-Saïdi, et al.
Trends in Genetics : TIG|June 4, 2026
Emerging role of G-quadruplexes in alternative splicing regulationAline Peynet, Ronan Le Sénéchal, Marc Keruzoré, et al.
Vaccine|September 26, 2024
Saccharomyces cerevisiae as a platform for vaccination against bovine mastitisCélya Danzelle, Patricia Cunha, Pablo Gomes Noleto, et al.
European Journal of Medicinal Chemistry|June 8, 2019
Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNAOksana Reznichenko, Alicia Quillévéré, Rodrigo Prado Martins, et al.
Oncogene|April 13, 2004
Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubinsMarie Knockaert, Marc Blondel, Stéphane Bach, et al.
Disease Models & Mechanisms|June 3, 2015
Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapiesJean-Paul Lasserre, Alain Dautant, Raeka S Aiyar, et al.
Plos One|May 15, 2008
Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugsDéborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug, et al.
Pageof 8